Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Sector

Healthcare

Industry

Biotechnology

CEO

Mikkelsen, Jan

Employees

1,017

Website

ascendispharma.com

IPO Date

2015-01-28

Headquarters

Tuborg Boulevard 12, Hellerup, Capital Region of Denmark, 2900, Denmark

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Ascendis Pharma ASND

Ascendis Pharma Earnings Call Summary

Ascendis Pharma Earnings

Transcripts

Events

About Ascendis Pharma A/S

Ascendis Pharma
ASND